PD3-1-1: ABT-869, a multiple tyrosine kinase inhibitor, has promising activity in patients with non-small cell lung cancer (NSCLC) in a phase I dose escalation study

Ross Soo; Choon-Hua Thng; Norita Sukri; Chiung-Ing Wong; Soo-Chin Lee; Chien-Shing Chen; Rod Humerickhouse; Boon-Cher Goh

doi:10.1097/01.jto.0000283395.45098.ca

PD3-1-1: ABT-869, a multiple tyrosine kinase inhibitor, has promising activity in patients with non-small cell lung cancer (NSCLC) in a phase I dose escalation study

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283395.45098.ca ◽

2007 ◽

Vol 2 (8) ◽

pp. S458-S459

Author(s):

Ross Soo ◽

Choon-Hua Thng ◽

Norita Sukri ◽

Chiung-Ing Wong ◽

Soo-Chin Lee ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Phase I ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Dose Escalation ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

Phase I/II study of PF-06463922, an ALK/ROS1 tyrosine kinase inhibitor, in patients with advanced non-small-cell lung cancer harboring specific molecular alterations.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps2620 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS2620-TPS2620 ◽

Cited By ~ 4

Author(s):

Todd Michael Bauer ◽

Alice Tsang Shaw ◽

Ben Solomon ◽

Benjamin Besse ◽

Leonard P. James ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Phase I ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Molecular Alterations

Download Full-text

P84.20 VATS Right Upper Lobectomy for Advanced Non-Small Cell Lung Cancer After ALK-Tyrosine Kinase Inhibitor Administration.

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1219 ◽

2021 ◽

Vol 16 (3) ◽

pp. S666-S667

Author(s):

K. Yamamoto ◽

M. Kuwahara ◽

S. Yamamoto

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)01361-0 ◽

2003 ◽

Vol 57 (2) ◽

pp. S417-S418 ◽

Cited By ~ 14

Author(s):

K.E Rosenzweig ◽

E Yorke ◽

A Jackson ◽

R Nayak ◽

V.W Rusch ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non–small-cell lung cancer

Journal of Radiation Research ◽

10.1093/jrr/rry058 ◽

2018 ◽

Vol 60 (2) ◽

pp. 228-233

Author(s):

Kyoichi Kaira ◽

Akihiro Ono ◽

Yosuke Kamide ◽

Noriaki Sunaga ◽

Yasuhiko Koga ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Thoracic Radiation

Download Full-text

Egfr-Tyrosine Kinase Inhibitor (Tki) Rechallenge with Bevacizumab in Egfr-Mutant Non-Small Cell Lung Cancer (Nsclc)

Annals of Oncology ◽

10.1093/annonc/mdu349.65 ◽

2014 ◽

Vol 25 ◽

pp. iv452

Author(s):

K. Otsuka ◽

A. Hata ◽

R. Kato ◽

J. Takeshita ◽

C. Okuda ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Mutant

Download Full-text

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-2014 ◽

2018 ◽

Vol 25 (2) ◽

pp. 496-505 ◽

Cited By ~ 13

Author(s):

Florence Atrafi ◽

Harry J.M. Groen ◽

Lauren A. Byers ◽

Elena Garralda ◽

Martijn P. Lolkema ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Solid Tumors ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Extensive Stage

Download Full-text

Phase I dose escalation study using the deep inspiration breath hold technique to safely increase dose to 81 Gy in the treatment of inoperable non-small cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(00)80260-6 ◽

2000 ◽

Vol 48 (3) ◽

pp. 233 ◽

Cited By ~ 4

Author(s):

K.E Rosenzweig ◽

J Hanley ◽

B Mychalczak ◽

Z Fuks ◽

G Mageras ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell ◽

Breath Hold ◽

Deep Inspiration ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Deep Inspiration Breath Hold

Download Full-text

Raltitrexed (‘Tomudex’) and cisplatin in metastatic non-small cell lung cancer (NSCLC): Preliminary results of a Phase I dose-escalation study

European Journal of Cancer ◽

10.1016/s0959-8049(99)81422-1 ◽

1999 ◽

Vol 35 ◽

pp. S253 ◽

Cited By ~ 1

Author(s):

C. Manegold ◽

E. Buchholz ◽

R. Kloeppel ◽

C. Kreisel ◽

M. Smith

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Preliminary Results

Download Full-text

Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer

Journal of Pharmacy Practice ◽

10.1177/0897190019840596 ◽

2019 ◽

pp. 089719001984059

Author(s):

Emily Miao ◽

Nagashree Seetharamu ◽

Kevin Sullivan ◽

Stephen Eng ◽

Chung-Shien Lee

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Starting Dose

Download Full-text

Be-Positive: Beyond Progression After Tyrosine Kinase Inhibitor in Egfr-Positive Non-Small Cell Lung Cancer (Nsclc) Patients. Preliminary Results from a Multicenter Italian Observational Study

Annals of Oncology ◽

10.1093/annonc/mdu349.57 ◽

2014 ◽

Vol 25 ◽

pp. iv450

Author(s):

T. Vavala ◽

A. Follador ◽

M. Tiseo ◽

D. Galetta ◽

A. Montanino ◽

...

Keyword(s):

Lung Cancer ◽

Observational Study ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Nsclc Patients

Download Full-text